Lupin eyes global acquisition in to boost growth, market share
New Delhi: Drug major Lupin is eyeing acquisitions in various global markets, including the US, Latin America and Europe, as it looks to bolster its presence overseas. "When it comes to new markets,...
View ArticleCadila Healthcare Q3 profit rises 52% to Rs 282 cr
Drug firm Cadila Healthcare reported a 52 percent rise in its consolidated net profit to Rs 281.91 crore for the third quarter ended 31 December 2014 on back of robust sales. The post Cadila Healthcare...
View ArticleNatco Pharma gains 4.5% after filing ANDA with USFDA
Natco Pharma has filed new product applications with the US health regulator for generic version of drugs used in the treatment of nervous system disease and cancer. The post Natco Pharma gains 4.5%...
View ArticleOrchid Chemicals & Pharma zooms 16% in early trade on USFDA nod for generic drug
From its 52-week low level, the stock has so far gained a whopping 35 percent in last one week The post Orchid Chemicals & Pharma zooms 16% in early trade on USFDA nod for generic drug appeared...
View ArticleGlenmark gets tentative USFDA approval for Lacosamide tablets
Lacosamide Tablets is generic version of Vimpat Tablets of UCB Inc The post Glenmark gets tentative USFDA approval for Lacosamide tablets appeared first on Firstpost.
View ArticleNatco Pharma, partner clear patent case with Gilead, others over Tamiflu
In March last year, USFDA had granted tentative approval to Natco for the generic oseltamivir phosphate capsules The post Natco Pharma, partner clear patent case with Gilead, others over Tamiflu...
View ArticleGlenmark’s US arm receives US FDA approval for contraceptive tablets
New Delhi: Glenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive norgestimate ethinyl estradiol tablets. In a BSE filing, the company said...
View ArticleGlenmark receives USFDA approval for anti-fungal ointment
According to IMS Health sales data for the 12 months to April 2016, Glenmark said Nystatin and triamcinolone acetonide ointment achieved annual sales of around $37.5 million The post Glenmark receives...
View ArticleRPG Life Sciences enters deal to acquire Sun Pharma’s 7 brands
The move is in line with the company's strategy to focus on formulation business The post RPG Life Sciences enters deal to acquire Sun Pharma’s 7 brands appeared first on Firstpost.
View ArticleCipla gets USFDA nod for overactive bladder treating drug
Enablex tablets and generic equivalents had US sales of approximately $85 million for the 12 month period ending June 2016 The post Cipla gets USFDA nod for overactive bladder treating drug appeared...
View Article